TrialArthritis research & therapy2015

Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial.

Patrick Verschueren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.